Ignite Creation Date:
2024-07-17 @ 11:42 AM
Last Modification Date:
2024-10-26 @ 3:32 PM
Study NCT ID:
NCT06465953
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-06-20
First Post:
2024-06-14
Brief Title:
Ivosidenib IVO Monotherapy and Azacitidine AZA Monotherapy in Patients With Hypomethylating Agent HMA Naive Myelodysplastic Syndromes MDS With an IDH1 Mutation
Sponsor:
Institut de Recherches Internationales Servier
Organization:
Servier
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Hypomethylating Agent HMA Naive Myelodysplastic Syndromes MDS |
| Myelodysplastic Syndromes MDS |
Keywords: